Recent advance in clinical drug therapy for Alzheimer's disease / 中华神经医学杂志
Chinese Journal of Neuromedicine
; (12): 849-855, 2023.
Article
in Zh
| WPRIM
| ID: wpr-1035890
Responsible library:
WPRO
ABSTRACT
Alzheimer's disease (AD) is the first degenerative disease of the nervous system, but no drugs have been found to reverse AD progression. Starting from 2 major pathogenesis of AD, namely amyloid beta (Aβ) cascade and Tau protein, this study systematically reviews anti-Aβ or Tau protein AD new drugs that have entered clinical research; this study also expounds their clinical trial findings and mechanisms, and analyzes the reasons for their success or failure to provide a theoretical basis for AD drug exploitation.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Chinese Journal of Neuromedicine
Year:
2023
Type:
Article